mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.005 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.008 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |